Share:
Peer-Reviewed Publication
Am J Drug Alcohol Abuse2023;49(2):249-259.March 4, 2023Journal Article

Treatment retention and reductions in blood alcohol concentration (BAC) during the first 90 days of a telehealth program for alcohol use disorder.

Kevin A Hallgren1, Gantt P Galloway2, Katie Witkiewitz3, Paul Linde2, Bob Nix2, John E Mendelson2
1Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA USA.
2Ria Health, San Francisco, CA.
3Department of Psychology and Center on Alcohol, Substance Use, And Addictions, University of New Mexico, Albuquerque, NM, USA.

Abstract

Background: Alcohol use disorder (AUD) treatments, including medications, are increasingly offered via telehealth.Objective: This study characterizes 90-day treatment retention and changes in objectively measured blood alcohol concentration (BAC) in a large cohort receiving AUD telehealth.Methods: Patients received AUD treatment through Ria, a virtual (telehealth) program offering AUD treatment th…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.